FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/TMDX
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

TransMedics Group Inc (TMDX) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

TMDX trades at $67.34, up 1.25% today but facing bearish technical signals with strong selling pressure on moving averages. The company maintains solid fundamentals with 58.7% gross margins and 22.7% net income margins, though recent quarterly earnings missed expectations. Revenue grew to $605M in 2025 but profit margins compressed from 31.4% to 22.7% in 2026 projections. Multiple law firms are investigating potential fiduciary breaches by company directors.
Despite bearish technicals and margin pressure, analyst consensus remains strongly bullish with a $99.63 price target representing 48% upside. The stock offers growth potential but faces execution risks from heavy investments and ongoing legal investigations that could impact shareholder confidence near-term.
Read full analysis

Key Stats

  • Market Cap
    $2.52B
  • Volume
    2,470,906
  • Sector
    Health
  • 52W High
    $150.42
  • 52W Low
    $61.99
  • Typical Hold Time
    26 Days
  • Enterprise Value
    $2.92B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$72
52W Low: $61.99
14 May 2026
52W High: $150.42
01 Dec 2025

Track TransMedics Group Inc (TMDX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, TransMedics Group Inc has traded between a low of $61.99 and a high of $150.42, highlighting its annual price range. Buy and sell TransMedics Group Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Most Recent News

Content is generated by Aura AI

Dune completes SOC 2 Type II, boosting trust as tokenized assets hit $32.6B amid growing institutional blockchain use.

Dune has completed a SOC 2 Type II examination with no exceptions, providing institutional clients with verified assurance of its data security standards. This milestone comes as tokenized real-world assets doubled to $32.6 billion and stablecoin mar...

Market News
1 hour ago
Not Specified
Bullish
news icon
Dune completes SOC 2 Type II, boosting trust as tokenized assets hit $32.6B amid growing institutional blockchain use.

Opus Genetics completes dosing in Phase 1/2 trial for gene therapy targeting inherited retinal diseases

Opus Genetics has finished dosing the higher-dose Cohort 2 in its Phase 1/2 trial of OPGx-BEST1, a gene therapy for BEST1-related inherited retinal diseases like Best vitelliform macular dystrophy and autosomal recessive bestrophinopathy. Cohort 2 en...

Market News
2 hours ago
Na
Bullish
news icon
Opus Genetics completes dosing in Phase 1/2 trial for gene therapy targeting inherited retinal diseases

Purple renews WiFi partnership with Lucid Motors in Riyadh, enhancing connectivity for staff and visitors.

Purple has renewed its partnership with Lucid Motors to continue providing WiFi services across Lucid's operations in Riyadh. This renewal ensures that both staff and visitors have secure and easy internet access, supporting Lucid's growing presence ...

Market News
4 hours ago
Purple Press Team
Bullish
news icon
Purple renews WiFi partnership with Lucid Motors in Riyadh, enhancing connectivity for staff and visitors.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $2.52B
  • Volume
    2,470,906
  • Sector
    Health
  • 52W High
    $150.42
  • 52W Low
    $61.99
  • Typical Hold Time
    26 Days
  • Enterprise Value
    $2.92B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$72
52W Low: $61.99
14 May 2026
52W High: $150.42
01 Dec 2025

Track TransMedics Group Inc (TMDX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, TransMedics Group Inc has traded between a low of $61.99 and a high of $150.42, highlighting its annual price range. Buy and sell TransMedics Group Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!